Procedimientos y composiciones que implican miARN y moléculas inhibidoras de miARN

Una molécula de ácido nucleico de miARN sintético que comprende una secuencia con al menos 80 % de identidad de secuencia con la secuencia de miR-29 humana madura para su uso como un medicamento. The present invention concerns methods and compositions for introducing miRNA activity or function into...

Full description

Saved in:
Bibliographic Details
Main Authors KELNAR, KEVIN, OVCHARENKO, DMITRIY, BROWN, DAVID, CHENG, ANGIE, JARVIS, RICH, DEVROE, ERIC, FORD, LANCE, BYROM, MIKE
Format Patent
LanguageSpanish
Published 21.04.2015
Subjects
BEER
BIOCHEMISTRY
CHEMISTRY
COMPOSITIONS OR TEST PAPERS THEREFOR
COMPOSITIONS THEREOF
CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL ORENZYMOLOGICAL PROCESSES
CULTURE MEDIA
ENZYMOLOGY
MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEICACIDS OR MICROORGANISMS
METALLURGY
MICROBIOLOGY
MICROORGANISMS OR ENZYMES
MUTATION OR GENETIC ENGINEERING
PROCESSES OF PREPARING SUCH COMPOSITIONS
PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS
SPIRITS
VINEGAR
WINE
Online AccessGet full text

Cover

More Information
Summary:Una molécula de ácido nucleico de miARN sintético que comprende una secuencia con al menos 80 % de identidad de secuencia con la secuencia de miR-29 humana madura para su uso como un medicamento. The present invention concerns methods and compositions for introducing miRNA activity or function into cells using synthetic nucleic acid molecules. Moreover, the present invention concerns methods and compositions for identifying miRNAs with specific cellular functions that arc relevant to therapeutic, diagnostic, and prognostic applications wherein synthetic miRNAs and/or miRNA inhibitors are used in library screening assays.
Bibliography:Application Number: ES20100183596T